Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis
recent articles
CARPACCIO.cloud Attending 38th J.P. Morgan Healthcare Conference
CARPACCIO.cloud is attending the 38th J.P. Morgan Healthcare Conference in San Francisco, January 13th-16th meeting clients, partners and investors, accelerating its development. The 38th JP Morgan Healthcare conference is the premier...
AI around the globe: Pathologists and Scientists at multiple Charles River Laboratories’ locations use Aiforia Create Ten different pathologists and scientists spread around the world are all sharing an Artificial Intelligence (AI)...
AI diagnoses prostate cancer as well as pathologists
By: Michael Walter | January 09, 2020 from AiinHealthcare Researchers have developed a deep learning system capable of evaluating tissue samples and diagnosing prostate cancer at a level comparable with many...
Clinical-grade Computational Pathology: Alea Iacta Est Filippo Fraggetta J Pathol Inform 2019, 10:38 (11 December 2019) [ABSTRACT] [HTML FULL TEXT] [PDF] [Mobile HTML Full text ] [EPub] Whole-slide image...
American Cancer Society says advances in treating lung and skin cancers contributed to the 2.2% drop in cancer mortality By Brianna Abbott - WSJ The cancer death rate in the U.S. dropped 2.2% from 2016 to 2017, the largest single-year...
Partnership to leverage Illumina's extensive decentralised installed base with Roche's expertise in assay development and to provide broad access to clinical oncology next-generation sequencing Comprehensive genomic testing improves...
